Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE
NCT04275349 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-06-11
Summary
The main purpose of this trial is to observe whether Xingnaojing, intravenously administered within 24 hours of symptom onset on pre-hospital emergency ambulance, improves the Early neurological deterioration of acute stroke at 3 days.
Conditions
- Stroke
- Acute Ischemic Stroke
- Acute Intracranial Hemorrhage
Interventions
- DRUG
-
Xingnaojing injection within 24 hours of symptom onset
intravenously administered Xingnaojing injection within 24 hours of symptom onset on ambulance or at hospital
Sponsors & Collaborators
-
Beijing Emergency Medical Center
collaborator OTHER -
Beijing Tiantan Hospital
collaborator OTHER -
Beijing Hospital of Traditional Chinese Medicine
collaborator OTHER -
Centre for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine
collaborator UNKNOWN -
Xuanwu Hospital, Beijing
collaborator OTHER -
Beijing Friendship Hospital
collaborator OTHER -
Beijing Chao Yang Hospital
collaborator OTHER -
Beijing Shijitan Hospital, Capital Medical University
collaborator OTHER -
Beijing Fengtai Youanmen Hospital
collaborator UNKNOWN -
Beijing Jiangong Hospital
collaborator UNKNOWN -
Beijing Chaoyang Emergency Medical Center
collaborator UNKNOWN -
Beijing Chaoyang Integrative Medicine Emergency Medical Center
collaborator UNKNOWN -
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
collaborator OTHER -
Fangshan Hospital，Beijing University of Chinese Medicine
collaborator UNKNOWN -
Civil Aviation General Hospital
collaborator OTHER -
The First Hospital of Fangshan District,Beijing
collaborator OTHER -
Beijing Chinese Medicine Hospital-Pinggu Hospital
collaborator UNKNOWN -
Beijing Pinggu District Hospital
collaborator OTHER -
Dongzhimen Hospital, Beijing
lead OTHER
Principal Investigators
-
Ying Gao, MD · Dongzhimen Hospital, Beijing
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-20
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- China
Study Locations
More Related Trials
-
The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule
NCT00548223 ·Status: COMPLETED ·Phase: PHASE4
-
Dynamic Combination Therapy on Chinese Herbal Granules to Improve the Symptoms in Convalescent Phase of Ischemic Stroke
NCT01780480 ·Status: COMPLETED ·Phase: NA
-
Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM
NCT02334969 ·Status: COMPLETED ·Phase: PHASE4
-
Bloodletting Puncture in the Treatment of Acute Ischemic Stroke
NCT05266326 ·Status: UNKNOWN ·Phase: NA
-
Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke
NCT04199455 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Angong Niuhuang Wan for Stroke
NCT04236427 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke
NCT06049498 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
NCT03354026 ·Status: UNKNOWN ·Phase: PHASE4
-
A Registry Study on Shuxuetong (a Chinese Medicine Injection) Used in Twenty Hospitals
NCT01508403 ·Status: UNKNOWN
-
Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
NCT04200781 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trail of Integrative Medicine Approaches for Post-Stroke Cognitive Impairment
NCT04596072 ·Status: COMPLETED ·Phase: NA
-
Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke
NCT01428401 ·Status: COMPLETED ·Phase: PHASE2
-
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
NCT06857487 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine
NCT00351806 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Clinical Efficacy of Chinese Medicine Treatment of Sequelae of Apoplexy
NCT03077984 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment
NCT04910256 ·Status: COMPLETED ·Phase: PHASE4
-
Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke
NCT00966316 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Ischemic Apoplexy Syndrome Specificity and Acupuncture Intervention Research
NCT04528472 ·Status: UNKNOWN ·Phase: NA
-
China Stroke Registry for Patients With Traditional Chinese Medicine
NCT04921397 ·Status: UNKNOWN
-
Yiqi Huoxue Demolition and Recipes on Recovery Stage of Cerebral Infarction
NCT02846207 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
NCT01758536 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke
NCT00710164 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
NCT05731310 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction
NCT02544087 ·Status: UNKNOWN ·Phase: NA
-
Efficiency Study of Traditional Chinese Medicine (TCM) Versus Western Medicine (WM) on Ischemic Stroke
NCT00843765 ·Status: COMPLETED ·Phase: NA